Is the obesity drug market still a duopoly?
Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...
Notable healthcare headlines for the week: Walgreens Boots Alliance, AbbVie and Novo Nordisk in focus
Wall Street's major averages dipped for the week as investors wrestled with tariff twists from the Trump administration. The ...
The Copenhagen Post2h
Majority of shares in Saxo Bank sold to Swiss company
According to a press release, the Swiss Safra Sarasin Group has bought 70 percent of Saxo Bank.The Swiss have bought 70 percent of the shares from the previous owners, Chinese Geely Financial Denmark ...
Le Lézard20m
U.S. Medical Weight Loss Market Report 2025: The Impact of GLP-1s on Doctors, Hospitals, Clinics and Franchises - ResearchAndMarkets.com
The "U.S. Medical Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. This report presents a complete picture of the medical weight loss market in the ...